Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.280
-0.020 (-0.87%)
May 30, 2025, 3:09 PM - Market open
Larimar Therapeutics Stock Forecast
LRMR's stock price has decreased by -68.03% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Larimar Therapeutics stock ranges from a low of $10 to a high of $26. The average analyst price target of $19.63 forecasts a 760.96% increase in the stock price over the next year.
Price Target: $19.63 (+760.96%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 25, 2025.
Analyst Ratings
The average analyst rating for Larimar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 5 | 5 | 4 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 10 | 10 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +1,040.35% | Mar 25, 2025 |
| Baird | Baird | Buy Maintains $13 → $10 | Buy | Maintains | $13 → $10 | +338.60% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +601.75% | Mar 25, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +689.47% | Jan 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +557.89% | Jan 24, 2025 |
Financial Forecast
Revenue This Year
n/a
from 433.59M
Revenue Next Year
n/a
EPS This Year
-1.97
from -1.32
EPS Next Year
-2.09
from -1.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 45.9M | 169.1M | ||
| Avg | n/a | 8.4M | 80.5M | ||
| Low | n/a | n/a | 7.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 1,919.2% | ||
| Avg | - | - | 861.7% | ||
| Low | - | - | -8.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.71 | -0.90 | -0.89 | ||
| Avg | -1.97 | -2.09 | -1.72 | ||
| Low | -2.23 | -2.83 | -2.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.